EB
RGNX icon

Eastern Bank’s Regenxbio RGNX Stock Holding History

Eastern Bank’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.43K Hold
370
– – ﹤0.01% 930
2026
Q1 		$3.1K Hold
370
– – ﹤0.01% 976
2025
Q4 		$5.33K Hold
370
– – ﹤0.01% 957
2025
Q3 		$3.57K Hold
370
– – ﹤0.01% 934
2025
Q2 		$3.04K Hold
370
– – ﹤0.01% 860
2025
Q1 		$2.65K Hold
370
– – ﹤0.01% 905
2024
Q4 		$2.86K Hold
370
– – ﹤0.01% 871
2024
Q3 		$3.88K Buy
+370
New +$4.51K ﹤0.01% 834

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Eastern Bank's RGNX Position: Q2 2026 in Review

Eastern Bank held its Regenxbio (RGNX) position steady in Q2 2026 at 370 shares worth $4.43K. The position accounts for ﹤0.01% of the portfolio, ranked #930.

Eastern Bank first reported a position in RGNX in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.33K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Eastern Bank held 370 shares of Regenxbio worth $4.43K as of Q2 2026.
  • Eastern Bank left its Regenxbio share count unchanged in Q2 2026.
  • Regenxbio made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #930 holding.
  • Eastern Bank first reported a position in Regenxbio in Q3 2024 and has held it in 8 quarters since.
  • Eastern Bank's Regenxbio position peaked at $5.33K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.